Cogent Biosciences Target Price

See Cogent Biosciences's analyst price targets ($51) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$31.5

Average Target Price

$50.67

60.8% upside

3 analysts in the last 4 months

High: $55 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-17	Piper Sandler	$55	74.6% upside
2026-08-12	GuggenheimMichael Schmidt	$52	65.1% upside
2026-06-01	Stifel NicolausLaura Prendergast	$45	42.9% upside
2026-05-06	H.C. WainwrightRobert Burns	$55	74.6% upside
2026-02-19	Robert W. Baird	$35	11.1% upside
2026-02-18	Piper Sandler	$52	65.1% upside
2026-01-07	UBSMichael Yee	$60	90.5% upside
2026-01-06	H.C. Wainwright	$52	65.1% upside
2025-12-08	Jefferies	$48	52.4% upside
2025-11-11	Raymond JamesChris Raymond	$60	90.5% upside
2025-11-10	Stifel Nicolaus	$40	27% upside
2025-11-10	WedbushDavid Nierengarten	$38	20.6% upside
2025-10-15	Stifel Nicolaus	$16	49.2% downside
2025-09-02	Raymond James	$30	4.8% downside
2025-08-25	Guggenheim	$20	36.5% downside
2025-01-14	H.C. WainwrightRobert Burns	$14	55.6% downside
2024-09-24	CitigroupDavid Lebowitz	$15	52.4% downside
2024-09-03	CitigroupDavid Lebowitz	$13	58.7% downside
2024-09-03	H.C. WainwrightRobert Burns	$17	46% downside
2024-03-30	JefferiesKelly Shi	$20	36.5% downside
2022-12-14	Needham	$24	23.8% downside
2022-06-17	Raymond JamesChris Raymond	$22	30.2% downside
2022-06-10	Leerink PartnersChristopher Liu	$15	52.4% downside

Cogent Biosciences (COGT) FAQ

The latest target price for COGT is $51. Investors often review this figure alongside Cogent Biosciences's historical trend and sector peers before judging valuation or financial health.

Cogent Biosciences trades near $31.5 while the consensus target sits at $51 (60.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting COGT's target price ($51), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cogent Biosciences's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.